AVALON GLOBOCARE CORP (ALBT) Stock Price & Overview
NASDAQ:ALBT • US05344R3021
Current stock price
The current stock price of ALBT is 0.69 USD. Today ALBT is down by -2.28%. In the past month the price decreased by -18.76%. In the past year, price decreased by -85.89%.
ALBT Key Statistics
- Market Cap
- 3.974M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -9.75
- Dividend Yield
- N/A
ALBT Stock Performance
ALBT Stock Chart
ALBT Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ALBT. When comparing the yearly performance of all stocks, ALBT is a bad performer in the overall market: 97.59% of all stocks are doing better.
ALBT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALBT. ALBT may be in some trouble as it scores bad on both profitability and health.
ALBT Earnings
ALBT Forecast & Estimates
ALBT Groups
Sector & Classification
ALBT Financial Highlights
Over the last trailing twelve months ALBT reported a non-GAAP Earnings per Share(EPS) of -9.75. The EPS increased by 50.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -205.48% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALBT Ownership
ALBT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LB | LANDBRIDGE CO LLC-A | 39.98 | 5.766B | ||
| KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.505B | ||
| FRPH | FRP HOLDINGS INC | N/A | 431.538M | ||
| TCI | TRANSCONTINENTAL REALTY INV | N/A | 332.986M | ||
| MLP | MAUI LAND & PINEAPPLE CO | N/A | 314.063M | ||
| SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 271.107M | ||
| ARL | AMERICAN REALTY INVESTORS IN | N/A | 244.995M | ||
| OZ | BELPOINTE PREP LLC- CLASS A | N/A | 206.909M | ||
| SRG | SERITAGE GROWTH PROP- A | N/A | 159.949M | ||
| MAYS | MAYS (J.W.) INC | N/A | 93.627M | ||
| LPA | LOGISTIC PROPERTIES OF THE A | N/A | 80.691M | ||
| INTG | INTERGROUP CORP | N/A | 78.475M | ||
| CKX | CKX LANDS INC | N/A | 22.653M |
Related stock screener links
View all stocks in the Real Estate Operating Companies Industry | View all stocks in the Real Estate Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ALBT
Company Profile
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The firm is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Company Info
IPO: 2016-02-22
AVALON GLOBOCARE CORP
4400 Route 9, Suite 3100
Freehold NEW JERSEY US
Employees: 5
Phone: 17327804400
AVALON GLOBOCARE CORP / ALBT FAQ
Can you describe the business of AVALON GLOBOCARE CORP?
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The firm is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
What is the current price of ALBT stock?
The current stock price of ALBT is 0.69 USD. The price decreased by -2.28% in the last trading session.
Does ALBT stock pay dividends?
ALBT does not pay a dividend.
What is the ChartMill rating of AVALON GLOBOCARE CORP stock?
ALBT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists ALBT stock?
ALBT stock is listed on the Nasdaq exchange.
Is AVALON GLOBOCARE CORP (ALBT) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALBT.
Can you provide the ownership details for ALBT stock?
You can find the ownership structure of AVALON GLOBOCARE CORP (ALBT) on the Ownership tab.